Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Lifecore Biomedical, Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference scheduled for January 12-15, 2026, in San Francisco, California [1] - The company's management, including CEO Paul Josephs and CFO Ryan Lake, will engage in one-on-one meetings during the conference [1] Company Overview - Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products [2] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and serves global and emerging biopharmaceutical and biotechnology companies across various therapeutic categories [2] - Lifecore's capabilities include handling complex formulations in syringes, vials, and cartridges [2]